Profil bibliographique

Godfrey T Otieno

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

8Publications signalées

254Citations signalées

1Affiliations récentes

Institutions déclarées

London School of Hygiene & Tropical Medicine

Domaines associés

Viral Infections and Outbreaks ResearchVaccine Coverage and HesitancySARS-CoV-2 and COVID-19 ResearchHepatitis B Virus StudiesBacillus and Francisella bacterial research

Publications récentes

Accès ouvert 2026 preprintOpenAlex

A Heterologous 2-dose Strategy for an Ebola Virus Vaccine Using Adenovirus Type 26 and Modified Vaccinia Virus Ankara–Vectored Ebola Induces a Robust, Increased Cellular Immune Response in Sierra Leonean Volunteers

Abdoulie Drammeh, Marvin Joven Turyasingura, Claire Bisbooka, Martin Ssejjoba et autres

0 citationsResearch Square

Accès ouvert 2026 articleOpenAlex

Long-term safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccine regimen: a cohort study of previously vaccinated adults and children in Sierra Leone (the EBOVAC-Salone extension study)

Daniela Manno, Ahmed Dahiru Balami, Agnes Bangura, A Kamara et autres

0 citationsThe Lancet Regional Health - Africa

Accès ouvert 2023 articleOpenAlex

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone

E Choi, Boris Lacarra, Muhammed O. Afolabi, Boni Maxime Ale et autres

18 citationsThe Lancet Global Health

Accès ouvert 2023 articleOpenAlex

The Effect of Previous Exposure to Malaria Infection and Clinical Malaria Episodes on the Immune Response to the Two-Dose Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen

Daniela Manno, Catriona Patterson, Abdoulie Drammeh, Kevin K. A. Tetteh et autres

5 citationsVaccines

Accès ouvert 2022 articleOpenAlex

Safety and immunogenicity of an Ad26.ZEBOV booster dose in children previously vaccinated with the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen: an open-label, non-randomised, phase 2 trial

Daniela Manno, Agnes Bangura, Frank Baiden, A Kamara et autres

26 citationsThe Lancet Infectious Diseases

Accès ouvert 2022 articleOpenAlex

Ebola Virus Glycoprotein IgG Seroprevalence in Community Previously Affected by Ebola, Sierra Leone

Daniela Manno, Philip Ayieko, David Ishola, Muhammed O. Afolabi et autres

11 citationsEmerging infectious diseases

Accès ouvert 2021 articleOpenAlex

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial

Muhammed O. Afolabi, David Ishola, Daniela Manno, Babajide Keshinro et autres

98 citationsThe Lancet Infectious Diseases

Accès ouvert 2021 articleOpenAlex

Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial

David Ishola, Daniela Manno, Muhammed O. Afolabi, Babajide Keshinro et autres

96 citationsThe Lancet Infectious Diseases

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.